Követés
RIEKE ALTEN
RIEKE ALTEN
schlosspark-klinik, charite universitätsmedizin berlin
E-mail megerősítve itt: snafu.de
Cím
Hivatkozott rá
Hivatkozott rá
Év
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
JS Smolen, A Beaulieu, A Rubbert-Roth, C Ramos-Remus, J Rovensky, ...
The Lancet 371 (9617), 987-997, 2008
17492008
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
J Braun, J Brandt, J Listing, A Zink, R Alten, W Golder, E Gromnica-Lhle, ...
The Lancet 359 (9313), 1187-1193, 2002
16702002
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig
JM Kremer, R Westhovens, M Leon, E Di Giorgio, R Alten, S Steinfeld, ...
New England Journal of Medicine 349 (20), 1907-1915, 2003
14042003
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
C Gabay, P Emery, R Van Vollenhoven, A Dikranian, R Alten, K Pavelka, ...
The Lancet 381 (9877), 1541-1550, 2013
7962013
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological …
C Ritchlin, P Rahman, A Kavanaugh, IB McInnes, L Puig, S Li, Y Wang, ...
Annals of the rheumatic diseases 73 (6), 990-999, 2014
7092014
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
J Braun, T Pham, J Sieper, J Davis, SJ Van der Linden, M Dougados, ...
Annals of the rheumatic diseases 62 (9), 817-824, 2003
6292003
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study
T Sokka, S Toloza, M Cutolo, H Kautiainen, H Makinen, F Gogus, V Skakic, ...
Arthritis research & therapy 11, 1-12, 2009
5502009
Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose‐finding, double‐blind, placebo‐controlled clinical trial evaluating CTLA‐4Ig and LEA29Y eighty‐five …
LW Moreland, R Alten, F Van den Bosch, T Appelboom, M Leon, P Emery, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2002
4832002
Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised …
F Buttgereit, G Doering, A Schaeffler, S Witte, S Sierakowski, ...
The Lancet 371 (9608), 205-214, 2008
4392008
Physical inactivity in patients with rheumatoid arthritis: data from twenty‐one countries in a cross‐sectional, international study
T Sokka, A Häkkinen, H Kautiainen, JF Maillefert, S Toloza, ...
Arthritis Care & Research: Official Journal of the American College of …, 2008
4192008
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their …
N Schlesinger, RE Alten, T Bardin, HR Schumacher, M Bloch, A Gimona, ...
Annals of the rheumatic diseases 71 (11), 1839-1848, 2012
3982012
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study
T Sokka, H Kautiainen, T Pincus, SMM Verstappen, A Aggarwal, R Alten, ...
Arthritis research & therapy 12, 1-10, 2010
3602010
Long‐term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three‐month, randomized, placebo‐controlled …
J Braun, J Brandt, J Listing, A Zink, R Alten, G Burmester, W Golder, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2003
3352003
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients …
J Detert, H Bastian, J Listing, A Weiß, S Wassenberg, A Liebhaber, ...
Annals of the rheumatic diseases 72 (6), 844-850, 2013
2582013
The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis
R Alten, H Gram, LA Joosten, WB Berg, J Sieper, S Wassenberg, ...
Arthritis research & therapy 10, 1-9, 2008
2562008
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and …
R Westhovens, PC Taylor, R Alten, D Pavlova, F Enríquez-Sosa, M Mazur, ...
Annals of the rheumatic diseases 76 (6), 998-1008, 2017
2452017
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled …
J Haschka, M Englbrecht, AJ Hueber, B Manger, A Kleyer, M Reiser, ...
Annals of the rheumatic diseases 75 (1), 45-51, 2016
2442016
Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years
J Braun, X Baraliakos, J Brandt, J Listing, A Zink, R Alten, G Burmester, ...
Rheumatology 44 (5), 670-676, 2005
2402005
Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised …
J Braun, J Zochling, X Baraliakos, R Alten, G Burmester, K Grasedyck, ...
Annals of the rheumatic diseases 65 (9), 1147-1153, 2006
2302006
Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate
MC Genovese, A Covarrubias, G Leon, E Mysler, M Keiserman, R Valente, ...
Arthritis & Rheumatism 63 (10), 2854-2864, 2011
2282011
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20